Skip to main content

Table 2 ADA levels in sera from patients treated with IFX and untreated healthy controls

From: B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera

Patient ID Age Gender ADA (µg/ml) Control ID Age Gender ADA (µg/ml)
438 29 M 54.1 P* 48 F <1.25
452 30 F 63.9 F10 20 M <1.25
485 64 F 74.1 F22 25 F <1.25
522 42 F 45.9 F28 22 M <1.25
587 41 F 78.4 F31 45 M <1.25
609 30 M >80 F32 59 F <1.25
623 57 F 53.9 F33 25 F <1.25
626 57 F 44.1 F38 53 F <1.25
638 32 M 39.3 F41 19 M <1.25
639 33 M 47.4 F42 32 M <1.25
648 4 F 34.2 F43 31 F <1.25
652 31 M 29.7 F44 44 F <1.25
660 26 M 14.4 F45 36 F <1.25
681 24.1 F46 35 F <1.25
694 13 F 45.6 F47 33 F <1.25
695 37 M 59.9     
719 16 F 69.7     
721 >80     
722 42 M 44.8     
724 80 F 32.6     
  1. Specific anti-drug-antibody (ADA) levels gainst IFX were determined by ELISA. The ADA detection range is 1.25–80 µg/ml
  2. –, patient information not available